Published Date: 02 Mar 2023
Researchers from the Barts Cancer Institute and the Francis Crick Institute at Queen Mary University of London have discovered why patients with rare blood cancers suffer from the development of poor red blood cells and...
Read Full NewsJean Bourbeau, MD, says AI analysis of CT scans is not ready for routine use but could reshape early COPD diagnosis as GOLD expands its AI guidance.
A TETON-2 post hoc analysis at CHEST 2026 found 126 progression events with inhaled treprostinil vs 161 with placebo across 52 weeks.
Voceryq Gains FDA Accelerated Approval for Recurrent Respiratory Papillomatosis
Shaida Khan, DO, associate professor of neurology at UT Southwestern Medical Center, reflected on a recent NeurologyLive Clinical Forum on generalized myasthenia gravis and discussed how FcRn and complement inhibitors are reshaping treatment algorithms for the disease.
Take 5 minutes to catch up on NeurologyLive®'s highlights from the week ending October 30, 2026.
Although ocular signs in LEMS are typically mild and appear late, recognizing them alongside proximal weakness and autonomic symptoms can speed diagnosis and earlier detection of an associated lung cancer.
Balcinrenone Plus Dapagliflozin Lowers BP, With Adriana Marton, MD
1.
Do I qualify for a cancer clinical trial?
2.
King Charles' Cancer; COVID Vax Now or Later; Was RFK Jr. a Drug Dealer?
3.
Drugmaker Pulls Trodelvy's Bladder Cancer Approval
4.
Lung Transplant for Lung Cancer: Promising, in Rare Cases
5.
Study finds higher breast cancer rates in areas with more air pollution
1.
Tumor Exposure-Response Modeling: Clinical Implications and Advances
2.
Nuclear Medicine's Role in Battling Women's Cancers
3.
Public Health Planning for Equitable Access to Advanced Hematology Services
4.
Single-Cell Profiles of Treatment-Refractory Blood Disease
5.
Unlocking the Potential of Sarclisa: A New Hope for Cancer Treatment
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
2.
"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC
3.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
4.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II
5.
Navigating the Complexities of Ph Negative ALL - Part III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation